| Univariate |  | Multivariate | ||
---|---|---|---|---|---|
Variable | OR(95% CI) | P value | Â | OR(95% CI) | P value |
Age(year) | 0.94(0.88–0.99) | 0.024 |  | 0.97(0.90–1.04) | 0.324 |
Female n(%) | 0.64(0.23–1.84) | 0.410 |  |  |  |
Weight(kg) | 1.03(0.99–1.07) | 0.138 |  |  |  |
BMI(kg/m2) | 1.08(0.92–1.26) | 0.349 |  |  |  |
AF duration (months) | 0.99(0.97–1.01) | 0.311 |  |  |  |
LVEF(%) | 0.92(0.82–1.03) | 0.133 |  |  |  |
LVDd(mm) | 0.86(0.78–0.95) | 0.004 |  | 0.85(0.76–0.95) | 0.005 |
LAD(mm) | 0.99(0.88–1.10) | 0.820 |  |  |  |
Hypertension(%) | 1.00(0.36–2.81) | 1.000 |  |  |  |
Diabetes(%) | 0.56(0.11–2.78) | 0.475 |  |  |  |
CHD(%) | 0.92(0.29–2.93) | 0.883 |  |  |  |
Previous stroke n(%) | 1.49(0.45–4.96) | 0.520 |  |  |  |
NT-pro BNP(pg/ml) | 1.00(1.00–1.00) | 0.221 |  |  |  |
Hb(g/L) | 1.02(1.00-1.06) | 0.105 | Â | Â | Â |
eGFR(ml/min/1.73m2) | 1.04(1.01–1.07) | 0.009 |  | 1.01(0.98–1.06) | 0.395 |
TC(mmol/L) | 1.41(0.75–2.66) | 0.284 |  |  |  |
TG(mmol/L) | 0.75(0.24–2.33) | 0.617 |  |  |  |
LDL-C(mmol/L) | 0.97(0.90–1.05) | 0.470 |  |  |  |
HDL-C(mmol/L) | 8.91(0.69–114.90) | 0.094 |  | 7.35(0.26-208.54) | 0.243 |
ACEI/ARB/ARNI n(%) | 0.91(0.28–2.96) | 0.879 |  |  |  |
\(\beta\)-block n(%) | 0.53(0.14–2.04) | 0.354 |  |  |  |
Diuretic n(%) | 0.68(0.23–1.99) | 0.477 |  |  |  |
SGLT-2 n(%) | 0.56(0.11–2.78) | 0.475 |  |  |  |
Digoxin n(%) | 0.71(0.18–2.81) | 0.621 |  |  |  |
EAT volume(cm3) | 1.00(0.99–1.02) | 0.816 |  |  |  |
LA-EAT volume (cm3) | 0.99(0.96–1.03) | 0.546 |  |  |  |
LVZs n(%) | 5.04(1.68–15.13) | 0.004 |  | 0.26(0.07–0.96) | 0.043 |
Recurrence of AF n(%) | 1.11(0.31–3.99) | 0.869 |  |  |  |